Furthermore, PAI-1 has been shown to induce endothelial dysfunction and atherosclerosis through antifibrinolytic-dependent mechanisms including inflammation [29], endothelial nitric oxide synthase (eNOS) inhibition [30], neointimal hyperplasia [31], and vascular senescence [28]. The gene discussed is NOS3; the disease is endothelial dysfunction.